ABSTRACT
OBJECTIVE: Diffuse coronary artery disease makes cardiac surgeons hesitant regarding whether coronary artery bypass grafting (CABG) surgery is feasible or not. Coronary artery reconstruction using the internal thoracic artery (ITA) allows bypassing of coronary arteries with diffuse atheromatous plaques without systematically resorting to endarterectomy. The aim of the present study was to evaluate the medium-term results of coronary artery reconstruction. METHODS: All patients undergoing coronary artery reconstruction using the ITA between 1999 and 2002 (233 patients) were included in the study. The mean age was 61.9 ± 9.8 years. Two hundred and eighty-one coronary artery reconstructions using the ITA were performed (mean length 3.6 ± 2 cm) for 514 CABGs. Coronary artery reconstruction using the ITA was associated with endarterectomy in 48 cases (17%). RESULTS: In-hospital mortality was 2.6%. Follow-up data were compiled in December 2008. Mean follow-up was 73.4 ± 16.7 months. The actuarial survival rate at 7 years was 89.3 ± 2.1%, and 88% of patients were free of major cardiac events at 7 years. CONCLUSIONS: Coronary artery reconstruction gives comparable medium-term results to conventional coronary surgery, even though it is indicated for patients with more severe lesions.
Subject(s)
Coronary Artery Disease/surgery , Mammary Arteries/transplantation , Aged , Coronary Artery Bypass/methods , Coronary Artery Bypass/mortality , Coronary Artery Disease/mortality , Exercise Tolerance/physiology , Female , Hospital Mortality , Humans , Male , Middle Aged , Postoperative Complications/mortality , Risk Factors , Survival Analysis , Treatment OutcomeABSTRACT
To better understand the effect of the internal thoracic artery on endothelial growth after open coronary endarterectomy, we designed an experimental test of the hypothesis that closing an endarterectomized artery by an arterial patch improves re-endothelialization. The two carotid arteries were endarterectomized in nine sheep and were randomly chosen for closure by native arterial femoral (ART) patch or polytetrafluoroethylene (PTFE) patch. Three animals were randomly chosen for sacrifice at 8, 15 and 21 days each. The endarterectomized segments were studied macroscopically and microscopically. The endarterectomized area covered with adhesive thrombus was more extensive in the PTFE than in the ART group (P=0.0117). In the ART group, the regenerated endothelium was normal and sprouted from the edges of both the endarterectomy and the arterial patch towards the central endarterectomized area. In the PTFE group, it sprouted from the edges of the endarterectomy and never reached the central endarterectomized area, where abnormal endothelium was observed. The endarterectomized area covered with normal endothelium was more extensive in the ART than in the PTFE group at 8 days, at 15 days, and 21 days (P<0.001). Arterial patch closure of open-endarterectomized artery improved regenerated endothelium quality.
Subject(s)
Blood Vessel Prosthesis Implantation , Carotid Arteries/surgery , Cell Proliferation , Coronary Vessels/surgery , Endarterectomy, Carotid/methods , Endothelium, Vascular/surgery , Femoral Artery/transplantation , Mammary Arteries/transplantation , Animals , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/instrumentation , Carotid Arteries/ultrastructure , Coronary Vessels/pathology , Endarterectomy, Carotid/instrumentation , Endothelium, Vascular/ultrastructure , Models, Animal , Polytetrafluoroethylene , Prosthesis Design , Sheep , Suture Techniques , Time Factors , Transplantation, AutologousABSTRACT
A homemade mitral annular prosthesis has been developed using expanded-polytetrafluoroethylene material. It is safe in that it avoids the risk of prosthesis wrinkle when stitches are tied. Simultaneously, it is strong enough to prevent future stretching and rupture. This device has been implanted in 60 patients with good and stable results at 42 months of follow-up. Our flexible mitral annular prosthesis is cost-effective and easily available in developing countries.
Subject(s)
Heart Valve Prosthesis , Mitral Valve Insufficiency/surgery , Mitral Valve/surgery , Follow-Up Studies , Heart Valve Prosthesis Implantation/methods , Humans , Mitral Valve/diagnostic imaging , Mitral Valve Insufficiency/diagnostic imaging , Polytetrafluoroethylene , Prosthesis Design , Retrospective Studies , Suture Techniques , Treatment Outcome , UltrasonographyABSTRACT
The aim of this study was to assess whether the continuous retrograde blood cardioplegia ensures prolonged aortic cross-clamping time without increasing the operative risk. From 1996 to 2003, 204 consecutive patients who had cardiac procedure requiring aortic cross-clamping time > or = 150 min, were prospectively included in this study: low risk group (EuroSCORE < or = 2) 50 patients, medium risk group (EuroSCORE 3-5) 68 patients, high risk group (EuroSCORE > or = 6) 86 patients. The myocardial protection associated induction of cardiac arrest by antegrade injection of hyperkalemic warm blood, continuous retrograde intermediate lukewarm (20 degrees C) blood cardioplegia, retrograde warm blood reperfusion and systemic normothermia. The mean aortic clamping time was 187+/-45 min (range 150-436 min). The mean cardiopulmonary bypass time was 245+/-73 min (range 168-653 min). The operative mortality was 8.3% (17 patients). The mean predicted mortality of the population studied (EuroSCORE logistic method) was 8.4%+/-12 (range 0.87%-76.15%) with a 95% confidence interval of 6.7% to 10%. The observed mortality was not different from the predicted mortality. Continuous retrograde intermediate lukewarm blood cardioplegia associated with systemic normothermia allows prolonged aortic clamping time for complex intervention without increase of operative mortality and morbidity.
